Latest Immucor Inc. Stories
Addresses critical unmet needs in blood banking and transfusion medicine - a fast, FDA-approved way to generate critical genetic matching information necessary to: NORCROSS, Ga.,
Reportbuyer.com just published a new market research report:
NEW YORK, Aug. 15, 2011 /PRNewswire/ -- Valassis Communications Inc. (NYSE: VCI) will replace Immucor Inc. (NASD: BLUD) in the S&P MidCap 400 index after the close of trading on Thursday, August 18, 2011.
NORCROSS, Ga., April 30 /PRNewswire-FirstCall/ -- Immucor, Inc. (Nasdaq: BLUD), a global leader in providing automated instrument-reagent systems to the blood transfusion industry, today announced that its fourth generation automated instrument, NEO(TM), has been cleared for marketing in the U.S.
NORCROSS, Ga., April 12 /PRNewswire-FirstCall/ -- Immucor, Inc.
In the news release, Immucor Announces Fiscal Third Quarter Results, issued 31-Mar-2010 by Immucor, Inc. over PR Newswire, several numbers in the first line of the table titled Selected Product Revenue and Gross Margin were transmitted incorrectly by PR Newswire.
NORCROSS, Ga., March 31 /PRNewswire-FirstCall/ -- Immucor, Inc. (Nasdaq: BLUD), a global leader in providing automated instrument-reagent systems to the blood transfusion industry, today reported financial results for its fiscal 2010 third quarter ended February 28, 2010.
- The act of sweetening by admixture of some saccharine substance.